Search papers, labs, and topics across Lattice.
This study conducts a comprehensive quantitative analysis of multimodal biomarkers in Alzheimer's Disease (AD) by integrating tau-PET, structural MRI, cognitive scores, and genetic data from 789 subjects. The researchers quantify cross-modal mutual information and predictive dependencies, revealing significant redundancy and associations that enhance disease modeling and understanding of cognitive decline. Key findings include the identification of a dominant neurodegenerative trajectory and a statistical decomposition of tau-cognition relationships, which improve biomarker selection and interpretation in AD research.
A dominant neurodegenerative trajectory linked to cognitive decline was identified, revealing critical insights into the interplay of multimodal biomarkers in Alzheimer's Disease.
Despite increasing adoption of multimodal approaches in Alzheimer's Disease (AD) research -- aimed at integrating molecular, structural, clinical, and genetic biomarkers to enhance disease characterization -- the relationships among these modalities remain poorly understood. A systematic analysis of their dynamic interaction is essential for improving disease modeling, identifying redundant assessments, and reducing patient burden and acquisition costs. In this paper, we present a quantitative analysis of multimodal AD biomarkers by integrating tau-PET, structural MRI, cognitive scores (MMSE and CDR), and APOE4 data from 789 subjects drawn from the ADNI dataset. In our analyses, we (A) quantify cross-modal mutual information and explained variance to assess redundancy and predictive dependencies; (B) examine associations between tau topologies and structural atrophy across brain regions to select informative ROIs; (C) perform a statistical decomposition of the tau-cognition association into atrophy-related and atrophy-independent components; (D) and identify a dominant neurodegenerative trajectory that aligns with cognitive decline. This study provides a systematic characterization of cross-modal relationships, improving the interpretability and selection of biomarkers in AD. Code is publicly available at: https://github.com/antonioscardace/Multimodal-AD.
